Showing results (101-110 of 2,637) with videos related to
Sort By:
Pageof 264
Hematology (Amsterdam, Netherlands)|March 8, 2003
Immune reconstitution and tolerance after allogeneic hematopoietic stem cell transplantationMasahiro Imamura, Yutaka Tsutsumi, Yoko Miura, et al.Hematology (Amsterdam, Netherlands)|December 12, 2002
Autologous hematopoietic stem cell transplantation for refractory lymphomatoid granulomatosisJulie Lemieux, Vincent Bernier, Nadine Martel, et al.Hematology (Amsterdam, Netherlands)|December 12, 2002
Thrombus formation with rehydrated, lyophilized plateletsThomas H Fischer, Elizabeth P Merricks, Author P Bode, et al.Hematology (Amsterdam, Netherlands)|May 15, 2003
Imatinib Mesylate (Gleevec) is a useful agent in the salvage treatment of adults with relapsed/refractory Philadelphia positive acute leukemiasV Gupta, S Kamel-Reid, M D Minden, et al.Hematology (Amsterdam, Netherlands)|May 15, 2003
Outcome and toxicity of salvage treatment on patients relapsing after autologous hematopoietic stem cell transplantation--experience from a single centerTomas Büchler, Mar Hermosilla, Christelle Ferra, et al.Hematology (Amsterdam, Netherlands)|May 15, 2003
Decreased transfusion requirements in patients given stem cell allografts using a non-myeloablative conditioning regimen: a single institution experienceGuillermo J Ruiz-Argüelles, Briceida López-Martínez, David Gómez-Rangel, et al.Hematology (Amsterdam, Netherlands)|May 15, 2003
Acute promyelocytic leukemia: a case-based reviewVikas Gupta, Daniel Tabak, Armand KeatingHematology (Amsterdam, Netherlands)|September 24, 2002
Treatment of lymphoid malignancies with non-myeloablative stem cell transplantationM D Seftel, J Lavoie, M J Barnett, et al.Hematology (Amsterdam, Netherlands)|September 24, 2002
Superior vena cava syndrome after bone marrow transplantation caused by aspergillosis: a case reportH Takatsuka, T Wakae, A Mori, et al.Hematology (Amsterdam, Netherlands)|August 13, 2002
Management of the chronic leukemias: special considerations in the elderly patient. Part III rarer chronic myeloid leukemiasAlexander S D SpiersPageof 264